Morgan Petronelli

In this episode, we discuss the residency match process with Jay Wofford, MD, including how the entire process works, tips on what to do and what not do, questions you should ask yourself and what to do if you don’t match.

This week’s edition of The Mainstream Patient features stories on pore vacuums, psoriasis on POC skin, the difference between fillers and Botox, how to treat scars, plus more.

ICYMI, some of this week’s featured content includes stories on how mask usage worsens rosacea, why trichometric analysis is the key to finding an effective hair loss treatment, why some acne treatments are targeting the sebaceous gland, and more.

Incyte announces the FDA has accepted the NDA for ruxolitinib cream for priority review. Ruxolitinib cream is a topical selective janus kinase (JAK)1/JAK2 inhibitor intended for the treatment of atopic dermatitis.

Recent research shows prolonged face-mask usage leads to negative quality-of-life impact and worsening of disease for rosacea.

Sun Pharmaceuticals announces the publication of results from its 5-year extension studies evaluating the safety, efficacy and tolerability of tildrakizumab-asmn.

This week’s edition of The Mainstream Patient features stories on dermaplaning, active skincare ingredients, the history of Botox, plus more.

ICYMI, some of this week’s featured content includes content on the benefits of precision medicine, caring for LGBTQ+ patients, a new Legal Eagle column, how trichoscopy can aid with diagnosis of hair disorders, plus more.

Angelo Landriscina, MD, FAAD, discusses how to care for your LGBTQ+ patients while also effectively addressing their different dermatologic needs.

Angelo Landriscina, MD, FAAD, discusses how to care for your LGBTQ+ patients while also effectively addressing their different dermatologic needs.

This week’s edition of The Mainstream Patient features stories on psoriatic arthritis diagnosis, treating eczema on darker skin types, the efficacy of pore vacuums, plus more.

ICYMI, some of this week’s featured content includes articles on the oral, narrow-spectrum antibiotics for acne, the best practices for atopic dermatitis care, oxytocin and its effect on skin aging, plus more.

Almirall announces the launch of tirbanibulin (Klisyri), a novel microtubule inhibitor for the topical treatment of actinic keratosis on the face or scalp.

In this video interview with Dermatology Times, one expert discusses how narrow-spectrum antibiotics can both protect the skin and gut microbiome, as well as effectively treat acne.

Watch one expert detail the benefits and limitations when using oral antibiotics for the treatment of acne.

This week’s edition of The Mainstream Patient features stories on psoriatic arthritis medication, “slugging” to treat cystic acne, chemical peels for darker skin types, plus more.

ICYMI, some of this week’s featured content includes articles on the multiple modalities to revise scars, the future of dermatology, phase 3 results of tapinarof cream for plaque psoriasis, guidelines for the COVID-19 vaccine and dermal fillers, plus more.

ASDSA has issued a patient safety alert after videos surface online of children/teens self-injecting HA via “hyaluron pens”.

Joel Cohen, MD, gives a synopsis of a panel discussion he was recently a part of at the 2021 ODAC Dermatology, Aesthetic and Surgical Conference focusing on the postoperative treatment of scars using a variety of methods including lasers, filler and other modalities.

Dermavant announces positive results from an interim analysis of its PSOARING 3 safety study investigating tapinarof cream 1% for the treatment of plaque psoriasis in adult patients.

Gary Salman discusses how to protect the practice from cybercriminals, plus the risks of not having cybersecurity measures in place.

In this episode, Gary Salman, CEO of Black Talon Security, details how to best protect your practice from data breaches and cybercriminals, as well as the risks of not implementing cybersecurity measures into your practice and what to do if a data or email breach occurs.

From lasers to filler and microneedling, dermatologists have a broad menu of modalities for addressing the challenges of scars.

This week’s edition of The Mainstream Patient features stories on hidradenitis suppurativa, the rise of contact dermatitis, sebaceous filaments, coconut oil for the face, plus more.

In case you missed it, some of this week’s featured content includes the latest FDA approvals, newly published phase 3 data for tirbanibulin, oxytocin and its effect on skin aging, plus more.

Nicole Hayre, MD, FAAD, discusses her recent research related to oxytocin's effect on skin aging and how increased levels of oxytocin in the body can make the skin appear younger.

Topical microtubule inhibitor, tirbanibulin (Klisyri, Almirall), demonstrates positive results for treating actinic keratosis (AK) of the face and scalp, according recently published data from two phase 3 studies.

Dr. Angelo Landriscina discusses the recent rise and influence of TikTok over the dermatology industry.

This week’s edition of The Mainstream Patient features stories on tretinoin, dermal fillers, dermarolling, niacinamide, and more.

In case you missed it, some of this week’s featured content includes a new podcast episode on the popularity of TikTok for dermatologists, FDA approvals for Soliton’s RAP device for cellulite and Galderma’s Restylane Defyne for chin augmentation, enrollment commencement for a food supplement and skin inflammation study, plus more.